Our members and partners

Today Uppsala BIO has about 50 members and partners. They include a variety of life science companies, as well as supporting companies acting within the life science area, the two universities, Uppsala University Hospital, and representatives from local government. Together we plan and conduct activities that will ensure that the life science sector in the region will continue to flourish.

Uppsala University Hospital is one of Sweden’s largest hospitals with 8000 employees and 1100 beds. The aim of the hospital is to provide the best possible care for all its patients, regardless of disease, in a safe and secure environment. Uppsala University Hospital constantly develops and implements new knowledge, technology and skills in order to deliver exceptional services. Each year there are 58000 admissions, 330000 doctor appointments and 420000 out-patient treatments.

ALMI supports the development of competitive small and medium-sized businesses with the aim of promoting economic growth and innovation in Sweden. ALMI offers a unique combination of financing and business development services, which cover the entire process from idea to profitable business. ALMI is owned by the Swedish state and is the parent company of a group of subsidiaries.

AroCell develops and commercializes innovative biomarkers for cell growth within the field of diagnostic, prognostic and therapeutic applications. The initial project is an ELISA assay based on a universal tumor marker. The product will be licensed to diagnostic companies for further adaptation to clinical routine laboratories, and later the methodology will be applied in point of care testing.

Demographic change is impacting health care systems through the growing number of chronic diseases and the increasing occurrence of multiple conditions. At the same time, people are taking a more active role in managing their own health. Bayer focuses on researching, developing and marketing specialty-focused innovative medicines, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. We are committed to the principles of sustainable development. With our products we aim to improve people's quality of life.

Bolander & Co are insurance brokers, claims and risk analysis consultants, established in 1973 with vast expertise in insurance matters for clients in the life science business.
We accompany our clients through all the development phases in everything from insurance issues about laboratory equipment and the consequences of the absence of research grants to damage during clinical testing in other countries and process technology risk analysis.
By being in close proximity to the life science industry in Uppsala we have throughout the years built up solid insurance capability within this area, with regards to risk analysis and insurance techniques such as loss adjustment. Through our global network, we can utilize the same knowledge about legislation and regulations throughout the world to your advantage.

Our speciality is clinical conduct of hospital-based early phase clinical trials (phase 0/I-IIa) in patients and healthy volunteers in a dedicated 12-bed research clinic at the Akademiska University Hospital in Uppsala combined with two additional SMO sites in Uppsala and Linköping for phase II/III studies. The research clinic is approved by the Medical Products Agency for First-in-Human studies.

CONNECT Uppsala is an organization that provides support for entrepreneurs, such as seminars, workshops, business contacts and its unique “springboard” process. The vast network that CONNECT Uppsala has formed offers the entrepreneur valuable knowledge about innovation, business development, financing and marketing.

Double Bond Pharmaceutical is a fast growing pharmaceutical company which develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company consists in providing patients and the market with superior (more efficient and safe) products especially in areas where these needs are unmet.

Emplicure AB is a pharmaceutical company that develops new patentable pharmaceutical products based on drug delivery. Their platform technologies originate from the interface between the materials and pharmaceutical sciences. The product candidates are all based on a large unmet medical need and existing active substances. The products will after different development stages be sold or outlicensed to other pharmaceutical companies for the final documentation and marketing.

Galderma (former Q-Med) is an innovative medical device company that has constantly broken new ground with its products. Galderma develops, manufactures, markets and sells primarily medical implants with focus on the esthetic market. The majority of the products are based on the company’s patented technology, NASHA™ for the production of stabilized non-animal hyaluronic acid.

Gradientech is a young, expanding life science company developing and selling innovative cutting-edge assays and software solutions for advanced cell response analysis - our customers are academic and industrial researchers within areas such as cancer- and stem cell research. We are developing a diagnostic platform for rapid antibiotic susceptibility testing (AST) of blood culture samples, based on our core microfluidic technology. Innovative solutions for rapid AST are essential in the race to combat the constantly increasing antibiotic resistance.

H&P Search & Interim AB (H&P) is a leading Life Science Recruiting & Interim Staffing agency in the Nordics, headquartered in Stockholm. We are four equal partners, with > 100 years of experience from Management and Leadership roles from various parts of the Life Science Industry. H&P has broad expertise from both the scientific and the commercial side from executive management positions to specialists and subject matter experts and know the Life Science industry from inside. We own the company together and work together in teams - one for all, all for one, with all our assignments. All staff are certified to run the full competence based recruitment process including search/headhunting, interviewing, testing, references and background checks. Consultants (Interim Staffing) are employed by H&P and we provide all supporting services to accommodate consultants seamlessly into our client's organizations.

InDex Pharmaceuticals is an immunology focused biopharmaceutical company that is dedicated to discovering and developing treatments exclusively in disease states where there is a high, unmet medical need, and to personalised medicine.

Johnson & Johnson Vision Care, Inc. is committed to creating life-long solutions to vision care needs. Since the ACUVUE® Brand made its debut in 1987 as the world’s first disposable soft contact lens, the company has repeatedly brought innovative, quality, and scientific advancements to the industry. In 2017 Johnson & Johnson acquired AMO; a global leader in ophthalmic surgery known for world-class intraocular lenses used in cataract surgery. In addition to the cataract business, AMO has advanced laser vision (LASIK) technologies designed to enhance surgeon productivity and correct near sightedness, far sightedness and astigmatism. The acquisition also includes AMO’s consumer eye health products – over-the-counter drops for dry eye, as well as multipurpose solutions and hydrogen peroxide cleaning systems for patients who wear contact lenses.

Lidds LIDDS (Local Intelligent Drug Delivery System) is a Swedish pharmaceutical company developing innovative pharmaceutical products based on medical need and its proprietary drug delivery technology. Liproca® Depot is the first product being developed by LIDDS based on this drug delivery technology. It is a novel product targeted primarily for the treatment of prostate cancer.

Mercodia is a world-leading developer, manufacturer and distributor of high quality immunoassay kits. They specialize in ELISA assays for clinical as well as research applications, notably within diabetes, obesity and cardiovascular disease. Mercodia supplies products to all major international markets from its state-of-the-art facilities in Uppsala, Sweden.

Novavax develops, manufactures and sells modern adjuvants for utilization in vaccine development, antibody production and immunological research. The adjuvant products are based on the most recent development and patented formulation of the ISCOM technology platform. The company was founded in 1999 as a spin-off from the Swedish University of Agricultural Science in Uppsala to further develop the ISCOM technology and make it commercially available and accessible for the global market. As for today, Isconova is well established within the veterinary vaccine field and is at the same time successfully moving in to the human vaccine area.

Olink Proteomics provides the most efficient tool available for targeted human protein biomarker discovery, development and implementation. Our disease or biology-focused immunoassay panels enable rapid, high-throughput analysis, with exceptional data quality and minimal sample consumption. Using just 1 µl of sample, 92 biomarkers are assayed simultaneously on each panel, with results in only 24 hours. Olink’s Proximity Extension Assay (PEA) technology enables this high level of multiplexing, as this dual recognition, DNA-coupled method provides exceptional readout specificity. The current library enables rapid analysis of more than 1,000 validated protein biomarkers with less than 15 µl of sample. Olink panels are available via our Analysis Service or as kits. With over half a million samples analyzed and a team of specialist data scientists, Olink also has the expertise to maximize the success of protein biomarker studies. The company is headquartered in Uppsala, and also has a major regional office and service lab in Boston MA, as well as a rapidly expanding global sales organization.

Orexo is a pharmaceutical company focusing on developing treatments for pain and inflammation. The company has four products on the market as well as a broad project portfolio in late stages of development. Sales and product development are mainly carried out through worldwide partnership agreements with larger pharmaceutical companies.

Pelago Bioscience AB offers preclinical measurements of Target Engagement of Lead- and Candidate Drugs using our proprietary method: CETSA™. Our data and tests allow pharmaceutical R&D companies to select the right compounds for progression, saving time, increasing the quality and likelihood of success at a lower cost compared to other methodologies. The CETSA™ method also allows measurements in human we will develop and introduce companion diagnostics, stand-alone diagnostics and other biosensor/drug-target monitoring kits as well as licenses and automated devices based on the CETSA™ method.

Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Recipharm in Uppsala runs a dedicated facility for API manufacturing and subsequent pharmaceutical production as well as a multi-purpose manufacturing facility. Recipharm has the competence, flexibility and facilities to take on challenging projects which require custom tailored processes. With a broad range of expertise and technologies available, Recipharm offers support and services ranging from development and procurement to full-scale manufacturing, distribution, tech transfer, stability studies, and life cycle management. In addition to human pharmaceuticals, Recipharm can also supply medical devices and veterinary products.

Redhot diagnostics AB offers a unique business structure for academic researchers and academically risen R&D companies, which includes development, marketing and sales through a worldwide distribution network. Redhot´s business idea is to start a company with the researcher or alternatively become co-owner of their R&D company. Redhot will, together with the research partner maintain and develop the IPR in this company. The IPR is out-licensed to redhot for production and sales. The development of the product prototype to a finished kit is done in redhot. Profits from the sales are shared with the R&D company according to a license agreement. Redhot is interested in projects that have a prototype with little or no research work to be completed. We also make consulting works in the validation and verification of a product to CE-labelling and in developing production methods, control methods and quality control.

Healthy Animals – Safe Humans. The National Veterinary Institute, SVA, is a Swedish national authority that strives for good animal and human health, a good environment and sustainable food production. We are being exposed to increasing demands that livestock production is done under ethically acceptable conditions and that foodstuffs are produced from healthy animals free from contagious agents, growth hormones, pharmaceutical residues and other alien substances.

TdB Consultancy’s core business is dextran and dextran derivatives, but it also possesses expertise in most aspects of polysaccharide chemistry. This includes not only synthesis, but also chemical and physicochemical characterisation. TdB Consultancy specialises in the synthesis of fluorescent derivatives of polysaccharides. Apart from its FITC and TRITC-derivatives, a new range of fluorophores is under development.

Technogarden Life Science
Technogarden is a consultant- and recruitment company specialized in the Life Science, IT and Industry sector.
In the Life Science sector, we specialize in competences within laboratory science, biotechnology, quality management, regulatory compliance, validation, engineering, pharmacovigilance and project management.
Today we are around 500 co-workers distributed in 15 locations throughout Sweden and Norway and the company is a fully owned subsidiary of Norconsult AS.
All our consultant- and recruiter managers has their own work experience within their focus area - which means that we can understand a company´s individual needs as well as how and where to find that specific talent.
Together with our own bank of candidates and our large network and co-partners we can generate competence assignments with the speed, professionalism, service, knowledge and delivery capacity that you expect.
We believe that our personal and positive attitude and approach will give our clients that extra value.
Our strategy is concentrated to create growth in order to be able to generate good development opportunities for both our clients and co-workers.
We also want to define health and community benefit - making sure that our co-workers stay healthy and that they can give value back to the society.
website: www.technogarden.se

Thermo Fisher Scientific, formerly Phadia AB, develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. Thermo Fisher Scientific has remained the world leader in its field for more than 25 years and employs 1,300 people in 21 countries around the world. With their head offices in Uppsala Thermo Fisher Scientific has an international centre of competence right in the heart of knowledge. The location of the strategic, administrative and business developing activities is also home to Thermo’s substantial research and development as well as their state of the art manufacturing plants.

World Courier provides unparalleled specialty logistics services to drive the commercial success of our partners around the globe. For 50 years, we’ve delivered peace of mind through world-class supply chain programs, transportation services, storage of time and temperature-sensitive products.
We are redefining what’s possible by providing dedicated solutions for innovative, cutting-edge medicines including cell and gene therapies and through our daily work, we are united in our responsibility to create healthier futures.
With a presence in over 50 countries and powered by our 2,700+ associates, World Courier is driven by a commitment to excellence and provides customized solutions with global reach to increase access to healthcare; making us the most trusted specialty logistics company in the world.

STUNS Life science brings together companies, universities, healthcare and society to fuel innovation and stimulate growth in the life science sector. Together we advance the sector's international competitiveness.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok